Clinical toxicity of synthetic cannabinoid receptor agonist use

被引：0
|
作者：
Manini, Alex F. [1 ]
Hoffman, Robert S. [2 ]
Stimmel, Barry [3 ]
Vlahov, David [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Med Toxicol, New York, NY 10029 USA
[2] NYU, Sch Med, Div Med Toxicol, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA
[4] UCSF Sch Nursing, Off Dean, San Francisco, CA USA
来源：
CLINICAL TOXICOLOGY | 2015年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
269
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [1] Synthetic cannabinoid receptor agonist (SCRA) toxicity reported to the Victorian Poisons Information Centre
    Wong, Anselm Y.
    Macleod, Dawson
    Greene, Shaun L.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (04) : 396 - 397
  • [2] Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity
    Worob, Adam
    Wenthur, Cody J.
    [J]. VACCINES, 2022, 10 (08)
  • [3] Reviewing "apinaca", an emergent synthetic cannabinoid receptor agonist
    Dinamarca, F.
    Grifell, M.
    Galindo, L.
    Campillo, M.
    Torrens, M.
    Perez, V.
    Farre, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S626 - S626
  • [4] Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation
    Tebo, Collin
    Mazer-Amirshahi, Maryann
    Wax, Paul
    Campleman, Sharan
    Boyer, Edward
    Brent, Jeffrey
    Sheth, Amit
    Daniuaityte, Raminta
    Carlson, Robert
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2021, 53 (03) : 207 - 214
  • [5] Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study
    Hill, Simon L.
    Najafi, Javad
    Dunn, Michael
    Acheampong, Paul
    Kamour, Ashraf
    Grundlingh, Johann
    Blain, Peter G.
    Thomas, Simon H. L.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (08) : 638 - 643
  • [6] Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
    Finlay, David B.
    Thuy Nguyen
    Gamage, Thomas F.
    Chen, Shuli
    Barrus, Daniel G.
    Patel, Purvi R.
    Thomas, Brian F.
    Wiley, Jenny L.
    Zhang, Yanan
    Glass, Michelle
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
  • [7] Severe clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA: a report from the Identification Of Novel psychoActive substance study (IONA)
    Najafi, Javad
    Dunn, Michael
    Hill, Simon L.
    Thomas, Simon H. L.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (04) : 405 - 405
  • [8] Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA
    Seywright, Alice
    Torrance, Hazel J.
    Wylie, Fiona M.
    McKeown, Denise A.
    Lowe, David J.
    Stevenson, Richard
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (08) : 632 - 637
  • [9] A synthetic cannabinoid receptor agonist (AB-FUBINACA)-associated fatality
    Fernandez, Denise
    Hammer, Jennifer
    De Olano, Jonathan
    Nelson, Lewis S.
    Hoffman, Robert S.
    Su, Mark K.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (04) : 408 - 408
  • [10] Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist
    Meyyappan, Chitra
    Ford, Loretta
    Vale, Allister
    [J]. CLINICAL TOXICOLOGY, 2017, 55 (02) : 151 - 152
12345